ArticleHaematologica2019
Evidence for prevention of renal dysfunction associated with primary myelofibrosis by cytoreductive therapy.
Yasutaka Fukuda et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it